220 related articles for article (PubMed ID: 6966764)
1. The effects of 5-HT uptake- and MAO-inhibitors on L-5-HTP-induced excitation in rats.
Ortmann R; Waldmeier PC; Radeke E; Felner A; Delini-Stula A
Naunyn Schmiedebergs Arch Pharmacol; 1980 Mar; 311(2):185-92. PubMed ID: 6966764
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of [3H]5-hydroxytryptamine binding sites in chick embryo brain by monoamine oxidase inhibitors or fenfluramine and potentiation by d,l-5-hydroxytryptophan.
Soblosky JS; DuMontier G; Jeng I
J Neurochem; 1985 Dec; 45(6):1923-31. PubMed ID: 3932597
[TBL] [Abstract][Full Text] [Related]
3. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
Eur J Pharmacol; 2007 Jun; 565(1-3):105-12. PubMed ID: 17400208
[TBL] [Abstract][Full Text] [Related]
4. The 5-HT syndrome and the drug discrimination paradigm in rats: application in behavioral studies on the central 5-HT system.
Ortmann R
Pharmacopsychiatry; 1985 Mar; 18(2):198-201. PubMed ID: 3875109
[TBL] [Abstract][Full Text] [Related]
5. The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5-methoxy-N,N-dimethyltryptamine in the rat.
Rényi L
Br J Pharmacol; 1986 Aug; 88(4):827-35. PubMed ID: 3091132
[TBL] [Abstract][Full Text] [Related]
6. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan.
Sleight AJ; Marsden CA; Martin KF; Palfreyman MG
Br J Pharmacol; 1988 Feb; 93(2):303-10. PubMed ID: 2451963
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase inhibitors: nature of their interaction with rabbit pancreatic islets to alter insluin secretion.
Feldman JM; Chapman B
Diabetologia; 1975 Dec; 11(6):487-94. PubMed ID: 1107123
[TBL] [Abstract][Full Text] [Related]
8. Effects of co-administration of a selective serotonin reuptake inhibitor and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
Eur J Pharmacol; 2006 Feb; 532(3):258-64. PubMed ID: 16488409
[TBL] [Abstract][Full Text] [Related]
9. Behavioural hyperactivity in rats treated with selective monoamine oxidase inhibitors and LM 5008, a selective 5-hydroxytryptamine uptake blocker.
Ashkenazi R; Finberg JP; Youdim MB
Br J Pharmacol; 1983 Jul; 79(3):765-70. PubMed ID: 6418248
[TBL] [Abstract][Full Text] [Related]
10. Effects of inhibitors of 5-hydroxytryptamine uptake on plasma glucose and their interaction with 5-hydroxytryptophan in producing hypoglycaemia in mice.
Wilson GA; Furman BL
Eur J Pharmacol; 1982 Mar; 78(3):263-70. PubMed ID: 7040087
[TBL] [Abstract][Full Text] [Related]
11. Interactions of a non-selective monoamine oxidase inhibitor, phenelzine, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake.
Marley E; Wozniak KM
J Psychiatr Res; 1984; 18(2):173-89. PubMed ID: 6747915
[TBL] [Abstract][Full Text] [Related]
12. Combined inhibition of serotonin uptake and oxidative deamination attenuates audiogenic seizures in DBA/2J mice.
Sparks DL; Buckholtz NS
Pharmacol Biochem Behav; 1985 Nov; 23(5):753-7. PubMed ID: 4080761
[TBL] [Abstract][Full Text] [Related]
13. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
Green AR; Youdim MB
Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
[TBL] [Abstract][Full Text] [Related]
14. 5-HT-mediated myoclonus in the guinea pig as a model of brainstem 5-HT and tryptamine receptor action.
Luscombe G; Jenner P; Marsden CD
Adv Neurol; 1986; 43():529-43. PubMed ID: 2418649
[TBL] [Abstract][Full Text] [Related]
15. 5-Hydroxytryptophan (5-HTP) uptake and decarboxylation in the kitten brain.
Kitahama K; Jouvet A; Fujimiya M; Nagatsu I; Arai R
J Neural Transm (Vienna); 2002 May; 109(5-6):683-9. PubMed ID: 12111460
[TBL] [Abstract][Full Text] [Related]
16. Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.
Halberstadt AL; Buell MR; Masten VL; Risbrough VB; Geyer MA
Psychopharmacology (Berl); 2008 Nov; 201(1):55-66. PubMed ID: 18604652
[TBL] [Abstract][Full Text] [Related]
17. Backward walking induced by L-5-hydroxytryptophan in mice.
Shimomura K; Mori J; Honda F
Jpn J Pharmacol; 1981 Feb; 31(1):39-46. PubMed ID: 6973044
[TBL] [Abstract][Full Text] [Related]
18. 5-HT immunoreactive hypothalamic neurons in rat and cat after 5-HTP administration.
Sakumoto T; Sakai K; Jouvet M; Kimura H; Maeda T
Brain Res Bull; 1984 Jun; 12(6):721-33. PubMed ID: 6332660
[TBL] [Abstract][Full Text] [Related]
19. In vivo increase in hypothalamic cyclic AMP following 5-hydroxytryptophan administration in rats.
Bundman MC; Browning RA
Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):214-20. PubMed ID: 6092975
[TBL] [Abstract][Full Text] [Related]
20. [5-hydroxytryptophan decarboxylase (5-HTPD) and monoamine oxidase (MAO) activities in the embryonic pineal organ of Lacerta vivipara J. A qualitative and quantitative microscopic study of the uptake of 3H-5-HTP under experimental conditions and the histochemistry of MAO (author's transl)].
Meiniel A
J Neural Transm; 1977; 41(2-3):175-208. PubMed ID: 303281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
